Removal of pharmaceutical residues – what drives the development?
Government funds are currently being invested in feasibility studies and investments for upgrading wastewater treatment plants (WWTPs) with the aim of removing organic micropollutants, such as pharmaceutical residues. What driving forces lie behind the municipalities and water- and wastewater organizations work with this issue and do the investments end up where they contribute the most?










